Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Radiotherapy-induced abscopal effects in immune checkpoint inhibitor-refractory metastatic disease: results from a large multicenter real-world cohort study.
Journal: Oncoimmunology
Published: January 12, 2026
Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study.
Journal: Journal for immunotherapy of cancer
Published: September 15, 2025
Sex-specific differences in abscopal responses to combined radiotherapy and immune checkpoint inhibition-insights from a multicenter study.
Journal: Frontiers in immunology
Published: September 04, 2025
Constructing a Prognostic Model for Clear Cell Renal Cell Carcinoma Based on Glycosyltransferase Gene and Verification of Key Gene Identification.
Journal: International journal of molecular sciences
Published: August 31, 2025
Radiotherapy in patients with NSCLC developing progressive disease during immune checkpoint inhibition: Abscopal responses and survival.
Journal: Clinical and translational radiation oncology
Published: August 25, 2025
Discovery of KIN-8741, a Highly Selective Type IIb c-Met Kinase Inhibitor with Broad Mutation Coverage and Quality Drug-Like Properties for the Treatment of Cancer.
Journal: Journal of medicinal chemistry
Published: June 03, 2025
Integrative Single-Cell and Bulk RNA Sequencing Identifies a Glycolysis-Related Prognostic Signature for Predicting Prognosis in Pancreatic Cancer.
Journal: International journal of molecular sciences
Published: April 07, 2025
GPR15-guided CD8+ T regulatory cells control intestinal inflammation.
Journal: Nature
Published: November 18, 2024
RPL22L1 fosters malignant features of cervical cancer via the modulation of DUSP6-ERK axis.
Journal: Journal of translational medicine
Published: November 16, 2024
AMBRA1 controls the translation of immune-specific genes in T lymphocytes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 22, 2024
Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.
Journal: Nature immunology
Published: February 12, 2024
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition.
Journal: Journal of medicinal chemistry
Published: January 17, 2024
Last Updated: 09/26/2026